课题基金 / 基金详情

VIRAL GENES AS TARGETS FOR ANTIVIRAL DRUGS

VIRAL GENES AS TARGETS FOR ANTIVIRAL DRUGS
病毒基因作为抗病毒药物的靶标
批准号:
6274700
负责人:
JOHN C DRACH
金额:
$2.15万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30

项目摘要

项目成果

JOHN C DRACH的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The overall objective of our research is to identify new compounds which have the potential to become useful antiviral drugs and to investigate how promising compounds act at the cellular, molecular and biochemical level. Toward this end, we have derived by in vitro selection methods human cytomegalovirus (HCMV) and human immunodeficiency virus (HIV) strains which are resistant to active compounds. Using drug resistance as a marker, we are in the process of identifying which HCMV and HIV genes have mutated to produce drug resistant virus strains. Identification of such genes is providing detailed understanding of antiviral drug action. Furthermore, the proteins specified by the genes may be new targets for antiviral drugs. The specific objective requiring the use of GCG analysis software is to compare the sequence of the viral genes to related viral, mammalian, and prokaryotic genes to better understand the function of the viral gene and the action of new inhibitors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HCMV EVALUATION, BIOCHEMISTRY, AND VIRAL GENETICS
HCMV EVALUATION, BIOCHEMISTRY, AND VIRAL GENETICS
HCMV EVALUATION, BIOCHEMISTRY, AND VIRAL GENETICS
IN VITRO EVALUATION AND BIOCHEMISTRY